TipRanks
Go Ultimate55% OFF

PyroGenesis Canada (8PY1) AI Stock Analysis

0 Followers
DE:8PY1

PyroGenesis Canada

(Frankfurt:8PY1)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue GrowthStrong quarterly and year-to-date growth indicates improving commercial execution across the company’s project portfolio. If momentum persists, higher revenue can provide operating leverage, strengthen customer adoption, and support better absorption of fixed costs over the next several quarters.
Negative Factors
Persistent UnprofitabilityDeeply negative operating and net margins show that the current revenue base does not yet cover the company’s operating cost structure. Even with recent improvement, sustained losses can constrain reinvestment, weaken resilience, and delay internally funded growth.

PyroGenesis Canada (8PY1) vs. iShares MSCI Germany ETF (EWG)

-100%0%100%200%300%400%DE:8PY1+25.27%EWG+9.62%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 45.27M
Dividend Yield
―
Average Volume (3M)
450
Price to Earnings (P/E)
-4.1
Beta (1Y)
-0.45
Revenue Growth
4.86%
EPS Growth
21.67%
Country
Germany
Employees
88
Sector
Industrials
Sector Strength
63
Industry
Industrial - Machinery

PyroGenesis Canada Business Overview & Revenue Model

Company Description

Montréal-based PyroGenesis Canada Inc. is an international pioneer in the development, manufacturing, and commercialization of advanced plasma processes and systems. Their portfolio includes several proprietary technologies: DROSRITE efficiently reco...

PyroGenesis Canada Earnings Call Summary

Earnings Call Date:Aug 05, 2026(Q2-2026)|% Change Since:44.30%|Next Earnings Date:Jul 28, 2020
Earnings Call SentimentPositive

The call presents a largely positive operational and financial trajectory: strong top-line growth (+47% Q2, +55% YTD), meaningful reductions in SG&A (14% Q2, 27% YTD) and substantial improvements in comprehensive loss and EBITDA metrics. The company also reported multiple strategic technology milestones and commercial agreements that support future growth. Offsetting items include a modest decline in backlog quarter-over-quarter, ongoing negative net finance results compared with a one-time prior-year finance gain, lower contributions from certain product lines due to timing, and continued exposure to revenue irregularity and industry-wide margin pressures. On balance, the improvements in revenue, cost control, and operating performance outweigh the remaining risks and one-off comparisons.

Positive Updates

Strong Quarterly Revenue Growth
Revenue for Q2 2026 was $4.4M, up 47% year-over-year from $3.0M in Q2 2025. This was the company's best Q2 since 2022 and the second-best quarter overall since Q3 2022.

Negative Updates

Backlog Decline Quarter-over-Quarter
Backlog decreased modestly from $43.1M at Q1 to $40.0M as projects progressed, indicating some near-term recognition but less remaining contracted revenue than at the prior quarter.

Company Guidance

Management cautioned that revenue will remain lumpy due to percentage-of-completion accounting and project timing but said momentum is being carried into Q3, citing Q2 revenue of $4.4M (+47% YoY) and H1 revenue of $9.3M (+55% YoY); backlog stood at $40.0M (down from $43.1M in Q1, 88% denominated in USD) and is expected to be recognized over roughly the next three years. They confirmed gross margin at 32% (Q2 gross profit $1.4M; H1 $3.0M), highlighted Q2 cost discipline with SG&A of $3.1M (‑14% YoY; ~25% or ~$1.0M reduction in cash fixed costs) and H1 SG&A $5.4M (‑27%), net R&D $100k in Q2 ($300k H1), net finance expense $300k in Q2 ($500k H1), comprehensive loss improving to $1.1M in Q2 and $2.2M year‑to‑date, EBITDA loss narrowing to $0.6M Q2/$1.1M H1 and modified EBITDA to $0.5M Q2/$0.8M H1; key revenue drivers were Spark (+$0.7M), Torch Systems (+$0.4M), DROSRITE (+$0.5M) and U.S. Navy work (+$0.3M) offset by lower biogas/upgrading projects, and management reiterated focus on backlog execution, advancing commercial opportunities and continued cost management.

PyroGenesis Canada Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

DE:8PY1 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:REKOTSE:REKO65NeutralCAD 30.33M8.726.20%3.62%7.21%―
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
TSE:TLATSE:TLA47NeutralCAD 12.94M-14.37-5.66%―-8.43%-233.47%
TSE:ENWTSE:ENW46NeutralCAD 21.37M-12.10-16.94%―9.31%-124.29%
TSE:NXHTSE:NXH42NeutralCAD 27.18M-2.88-138.91%―374.59%74.40%
TSE:DYATSE:DYA40UnderperformCAD 50.83M-5.18718.52%―-57.68%24.90%

* Industrials Sector Average

Performance Comparison

0%200%400%600%DE:8PY1TSE:DYATSE:ENWTSE:REKOTSE:TLATSE:NXHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:8PY1 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:8PY1PyroGenesis Canada0.110.06123.53%
TSE:DYAdynaCERT Inc0.10-0.01-13.04%
TSE:ENWEnwave Corp0.19-0.19-50.00%
TSE:REKOReko International5.771.8848.33%
TSE:TLATitan Logix0.48-0.06-10.56%
TSE:NXHNext Hydrogen Solutions Inc0.40-0.20-33.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.